Amsino Medical Group announces transformational investment from Novo Tellus

POMONA, Calif., June 27, 2024 /PRNewswire/ — Amsino Medical Group (“Amsino”), a global provider of medical consumable devices, is pleased to announce the closing of a substantial investment by Novo Tellus, a leading investment firm specialising in long-term investments in the global…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks